383 related articles for article (PubMed ID: 23345940)
1. Prognostic value of innate and adaptive immunity in colorectal cancer.
Grizzi F; Bianchi P; Malesci A; Laghi L
World J Gastroenterol; 2013 Jan; 19(2):174-84. PubMed ID: 23345940
[TBL] [Abstract][Full Text] [Related]
2. Host response to colorectal cancer.
Salama P; Platell C
ANZ J Surg; 2008 Sep; 78(9):745-53. PubMed ID: 18844901
[TBL] [Abstract][Full Text] [Related]
3. Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer.
Wilkinson K; Ng W; Roberts TL; Becker TM; Lim SH; Chua W; Lee CS
J Clin Pathol; 2021 Oct; 74(10):625-634. PubMed ID: 33753562
[TBL] [Abstract][Full Text] [Related]
4. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
Front Immunol; 2020; 11():614300. PubMed ID: 33643296
[TBL] [Abstract][Full Text] [Related]
5. The immune microenvironment of the colorectal tumor: Involvement of immunity genes and microRNAs belonging to the TH17 pathway.
Omrane I; Benammar-Elgaaied A
Biochim Biophys Acta; 2015 Aug; 1856(1):28-38. PubMed ID: 25911397
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
Li X; Nie J; Mei Q; Han WD
World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
[TBL] [Abstract][Full Text] [Related]
8. The role of sex in the innate and adaptive immune environment of metastatic colorectal cancer.
Ray AL; Nofchissey RA; Khan MA; Reidy MA; Lerner MR; Wu X; Guo S; Hill SL; Weygant N; Adams SF; Castillo EF; Berry WL; Stout MB; Morris KT
Br J Cancer; 2020 Aug; 123(4):624-632. PubMed ID: 32451467
[TBL] [Abstract][Full Text] [Related]
9. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and prostate cancer: friends or foe?
Taverna G; Pedretti E; Di Caro G; Borroni EM; Marchesi F; Grizzi F
Inflamm Res; 2015 May; 64(5):275-86. PubMed ID: 25788425
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
13. Immune cells: plastic players along colorectal cancer progression.
Di Caro G; Marchesi F; Laghi L; Grizzi F
J Cell Mol Med; 2013 Sep; 17(9):1088-95. PubMed ID: 24151976
[TBL] [Abstract][Full Text] [Related]
14. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer Invasion and Atrophy of the Enteric Nervous System: Potential Feedback and Impact on Cancer Progression.
Godlewski J; Kmiec Z
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403316
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect.
Jacobs J; Smits E; Lardon F; Pauwels P; Deschoolmeester V
J Immunol Res; 2015; 2015():158038. PubMed ID: 26605342
[TBL] [Abstract][Full Text] [Related]
17. Biopolymer Immune Implants' Sequential Activation of Innate and Adaptive Immunity for Colorectal Cancer Postoperative Immunotherapy.
Ji G; Zhang Y; Si X; Yao H; Ma S; Xu Y; Zhao J; Ma C; He C; Tang Z; Fang X; Song W; Chen X
Adv Mater; 2021 Jan; 33(3):e2004559. PubMed ID: 33296110
[TBL] [Abstract][Full Text] [Related]
18. Tumor immune escape mechanisms that operate during metastasis.
Croci DO; Salatino M
Curr Pharm Biotechnol; 2011 Nov; 12(11):1923-36. PubMed ID: 21470132
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
Razmkhah M; Abtahi S; Ghaderi A
Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
